Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

502 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A new path to targeted protein degradation?
Mullard A. Mullard A. Nat Rev Drug Discov. 2022 Oct;21(10):706-707. doi: 10.1038/d41573-022-00147-6. Nat Rev Drug Discov. 2022. PMID: 36097157 No abstract available.
The UK Biobank at 20.
Mullard A. Mullard A. Nat Rev Drug Discov. 2022 Sep;21(9):628-629. doi: 10.1038/d41573-022-00137-8. Nat Rev Drug Discov. 2022. PMID: 35953651 No abstract available.
What should go into a booster shot for COVID-19?
Mullard A. Mullard A. Nat Rev Drug Discov. 2022 Aug;21(8):548. doi: 10.1038/d41573-022-00116-z. Nat Rev Drug Discov. 2022. PMID: 35794465 No abstract available.
Ipsen buys Epizyme for US$247 million.
Mullard A. Mullard A. Nat Rev Drug Discov. 2022 Aug;21(8):549. doi: 10.1038/d41573-022-00119-w. Nat Rev Drug Discov. 2022. PMID: 35794464 No abstract available.
502 results